Digital Health

DETECT™

Health System Clinical Solutions

Dual-Enzyme Trigger-Enabled Cascade Technology

At the heart of BioAmp's innovation is DETECT™, a proprietary chemistry-based platform designed to deliver actionable diagnostic results in minutes, rather than days. This technology enables the detection of antibiotic-resistant bacteria directly from unprocessed patient samples, such as urine, without the need for complex instrumentation.

Tech Brief
- BioAmp will first apply DETECT to direct care of complicated urinary tract infections, delivering results that enable physicians to treat their patients with RIGHT antibiotic the FIRST time.
  
  Rapid Results: Provides diagnostic outcomes in under 5 minutes, facilitating immediate clinical decision-making.
  
  Instrument-Free: Operates without the need for specialized laboratory equipment, making it suitable for point-of-care settings.
  
  High Sensitivity: Capable of detecting low-abundance β-lactamase enzymes, including CTX-M-type ESBLs, directly from patient samples.
  
  Colorimetric Readout: Utilizes a visible color change to indicate the presence of antibiotic-resistant pathogens, simplifying result interpretation.
  
  Targeted Application: Initially focused on complicated urinary tract infections (cUTIs), with plans to expand to other infection types.